Does exercise intensity matter for fatigue during (neo‐)adjuvant cancer treatment? The Phys‐Can randomized clinical trial
Ingrid Demmelmaier(Uppsala University), Karin Nordin(Uppsala University), Sussanne Börjeson(Linköping University), Maria Hellbom(Stockholm Health Care Services), Ann Christin Helgesen Bjørke(University of Agder), Anne‐Sophie Mazzoni(Uppsala University), Anna Henriksson(Uppsala University), Katarina Sjövall(Lund University), Laurien M. Buffart(Amsterdam Public Health), Silvia Johansson(Uppsala University), Galina Velikova(University of Leeds), Henrik Lindman(Uppsala University), Anna‐Karin Ax(Linköping University), Hannah L. Brooke(Uppsala University), Pernilla Åsenlöf(Uppsala University), Ronnie Pingel(Uppsala University), Sveinung Berntsen(University of Agder), Truls Raastad(Norwegian School of Sport Sciences), Birgitta Johansson(Uppsala University), Peter Nygren(Uppsala University), Neil K. Aaronson(The Netherlands Cancer Institute), Helena Igelström(Uppsala University)
Cited by 70
Related Papers
Cross-Validation of Item Selection and Scoring for the SF-12 Health Survey in Nine Countries
|Journal of Clinical Epidemiology|1998|2.9k
EORTC QLQ-C30 Scoring Manual
|Research at the University of Copenhagen (University of Copenhagen)|1995|2.4k
Translation, Validation, and Norming of the Dutch Language Version of the SF-36 Health Survey in Community and Chronic Disease Populations
|Journal of Clinical Epidemiology|1998|2.3k
Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer
|New England Journal of Medicine|2018|1.4k
Randomized Phase III Study of Temozolomide Versus Dacarbazine in the Treatment of Patients With Advanced Metastatic Malignant Melanoma
|Journal of Clinical Oncology|2000|1.3k